Yahoo Web Search

Search results

1. • 

     Novartis and Clarius partner for psoriatic arthritis care in Canada

     Medical Device Network via Yahoo Finance· 2 hours ago

     Novartis Pharmaceuticals Canada has partnered with Clarius Mobile Health to help improve access to...

2. • 

     Low stress resilience is linked to increased risk of psoriasis

     Medical Xpress· 7 days ago

     As part of the enlistment process, all the men underwent psychological assessment in accordance with...

3. • 

     What To Know and Do About Jaw Pain on One Side

     Health via Yahoo News· 2 days ago

     Cancer: Oral cancer can cause one-sided jaw pain, difficulty moving your mouth, and swelling in your jaw. Arthritis: Some forms of arthritis, including...

4. • Q2 2025 Earnings Estimate for Bristol-Myers Squibb Issued By Zacks Research (NYSE:BMY)

     ETF DAILY NEWS· 8 hours ago

     Bristol-Myers Squibb (NYSE:BMY – Free Report) – Investment analysts at Zacks Research raised their Q2 2025 earnings estimates for shares of Bristol-Myers Squibb in a research report issued on ...

5. • 

     J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial

     Clinical Trials Arena via Yahoo Finance· 7 days ago

     -inhibiting monoclonal antibody. It was first approved as a treatment for moderate to severe plaque...

6. • Alvotech (NYSE:ALVO) Releases Quarterly Earnings Results, Misses Estimates By $0.81 EPS

     ETF DAILY NEWS· 4 days ago

     Alvotech (NYSE:ALVO – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.89) earnings per share for the quarter, missing analysts’ consensus estimates ...

7. • 

     Inflammaging Could Be the Cause of Your Fatigue — How One Woman Finally Found Relief

     First for Women via Yahoo News· 3 days ago

     Over the years, I suffered from irritable bowel syndrome, acid reflux, a racing heart and high blood...

8. • Small Business - The Andalusia Star-News | The Andalusia Star-News

     The Andalusia Star-News· 2 hours ago

     - New study follows completion of first-in-human Phase 1b trial in atopic dermatitis patients, in which selectION observed safety and tolerability of si-544 in the treatment of T cell autoimmunity - Recruitment is underway, with topline results

9. • 

     Maintenance Tx With Guselkumab for UC Meets All Endpoints

     Medscape· 6 days ago

     Guselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...

10. • 

      Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief

      Verywell Health via Yahoo News· 7 days ago

      Takeaway Humira was one of the first biologic medications approved for psoriatic arthritis in 2005...